Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
1
Mins
3rd August 2015
‘Artificial Pancreas’ Could Revolutionise Control of Type 1 Diabetes
IMPLANTABLE ‘artificial pancreas’ may eliminate the use of insulin injections and pumps for individuals with Type 1 diabetes (T1D), potentially…
1
Mins
3rd August 2015
Genetic Variation Affects Potency of Anti-Diabetic Drug
EFFECTIVENESS of an anti-diabetic drug depends on small, natural differences in DNA among individuals, a discovery that has paved the way…
30th July 2015
Thrombosis in Haematological Disorders: Tailored Management Approaches
The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases.
30th July 2015
Why Biosimilars Matter: An Innovative Solution to Improve Patient Access
The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients Prof Foà opened the symposium by highlighting…
30th July 2015
Perspectives on the Treatment of Mantle Cell Lymphoma and Follicular Lymphoma in 2015 and Beyond
Prof Martin Dreyling opened the symposium by providing an overview of the current status of mantle cell lymphoma (MCL) and the current guidelines…
30th July 2015
Relapsed/Refractory Multiple Myeloma: The Current State of Play
Multiple myeloma (MM) usually responds to treatment but is incurable. The clinical course is characterised, in most patients, by a series of remissions…
July 2015
EMJ Hematology 3 [ePrint] 2015
The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients accessing therapies in the context of rising healthcare costs…
July 2015
EMJ Hematology 3.1 2015
Hello, and a very warm welcome to the new edition of EMJ Hematology, the source for the latest developments and innovations relating to the study of…
28th July 2015
IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis
The meeting was opened by Prof Atul Deodhar who introduced the prevalence, epidemiology, and clinical features of axial spondyloarthritis (axSpA), and…
28th July 2015
IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis
Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status of current disease…
←
1
2
3
…
823
824
825
826
827
828
829
…
897
898
899
→